Latham & Watkins Reps Boston Scientific In $1.3B Deal

Law360, New York (March 8, 2012, 9:25 PM EST) -- Boston Scientific Corp. will pay up to $1.3 billion to buy California-based Cameron Health Inc., strengthening its arrhythmia management portfolio with the addition of the only commercially available subcutaneous implantable cardioverter-defibrillator, the buyer said Thursday.

Narick, Mass.-based Boston Scientific said it would exercise its option to buy the privately held company with an upfront payment of $150 million, plus a potential $150 million additional payment upon U.S. Food and Drug Administration approval of the subcutaneous defibrillator system. It will pay up to another $1.05 billion based...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.